Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-23-024386

Prin. Fin. and Acctg. Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Donegan Michael C Prin. Fin. and Acctg. Officer 2023-04-12 Option exercise +50,000 61,853 D
Derivatives
Donegan Michael C Prin. Fin. and Acctg. Officer 2023-04-12 Option exercise · Restricted Stock Units −50,000 0 D
Loading xslF345X04/doc4.xml…